Daniel Abazia

528 total citations · 1 hit paper
6 papers, 370 citations indexed

About

Daniel Abazia is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Daniel Abazia has authored 6 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Surgery. Recurrent topics in Daniel Abazia's work include Cannabis and Cannabinoid Research (2 papers), Pain Management and Opioid Use (1 paper) and Biomedical and Engineering Education (1 paper). Daniel Abazia is often cited by papers focused on Cannabis and Cannabinoid Research (2 papers), Pain Management and Opioid Use (1 paper) and Biomedical and Engineering Education (1 paper). Daniel Abazia collaborates with scholars based in United States. Daniel Abazia's co-authors include Mary Barna Bridgeman, Christopher M. Herndon, Kyle P. Edmonds, Kashelle Lockman, Rabia S. Atayee, William L. Baker, J. Kevin Hicks, Donald C. Moore, Chi‐Hua Lu and Alexandre Chan and has published in prestigious journals such as International Journal of Clinical Practice, Expert Opinion on Pharmacotherapy and American Journal of Hospice and Palliative Medicine®.

In The Last Decade

Daniel Abazia

6 papers receiving 349 citations

Hit Papers

Medicinal Cannabis: History, Pharmacology, And Implicatio... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Abazia United States 5 279 66 54 43 43 6 370
Paul Couey United States 5 253 0.9× 61 0.9× 32 0.6× 40 0.9× 30 0.7× 10 344
John S. Finnell United States 7 248 0.9× 54 0.8× 63 1.2× 34 0.8× 44 1.0× 11 422
Ran Abuhasira Israel 10 351 1.3× 64 1.0× 53 1.0× 47 1.1× 73 1.7× 29 579
Rosyidah Arafat Indonesia 5 189 0.7× 50 0.8× 37 0.7× 20 0.5× 57 1.3× 32 270
Will Toperoff United States 4 274 1.0× 51 0.8× 34 0.6× 55 1.3× 44 1.0× 4 426
Jamie Corroon United States 9 524 1.9× 90 1.4× 84 1.6× 61 1.4× 77 1.8× 19 596
Eberhard A. Lux Germany 9 262 0.9× 84 1.3× 52 1.0× 70 1.6× 11 0.3× 37 539
Priyamvada Sharma India 9 346 1.2× 129 2.0× 41 0.8× 47 1.1× 45 1.0× 40 709
Irma de Vries Netherlands 9 222 0.8× 33 0.5× 45 0.8× 49 1.1× 39 0.9× 27 371
Craig Sadler Australia 8 230 0.8× 46 0.7× 45 0.8× 35 0.8× 93 2.2× 11 330

Countries citing papers authored by Daniel Abazia

Since Specialization
Citations

This map shows the geographic impact of Daniel Abazia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Abazia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Abazia more than expected).

Fields of papers citing papers by Daniel Abazia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Abazia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Abazia. The network helps show where Daniel Abazia may publish in the future.

Co-authorship network of co-authors of Daniel Abazia

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Abazia. A scholar is included among the top collaborators of Daniel Abazia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Abazia. Daniel Abazia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Chan, Alexandre, William L. Baker, Daniel Abazia, et al.. (2025). Impact of artificial intelligence on future clinical pharmacy research and scholarship. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(4). 311–316. 2 indexed citations
2.
Abazia, Daniel & Mary Barna Bridgeman. (2018). Reefer madness or real medicine? A plea for incorporating medicinal cannabis in pharmacy curricula. Currents in Pharmacy Teaching and Learning. 10(9). 1165–1167. 15 indexed citations
3.
Atayee, Rabia S., et al.. (2018). Multicentered Study Evaluating Pharmacy Students’ Perception of Palliative Care and Clinical Reasoning Using Script Concordance Testing. American Journal of Hospice and Palliative Medicine®. 35(11). 1394–1401. 11 indexed citations
4.
Abazia, Daniel, et al.. (2017). Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares. Expert Opinion on Pharmacotherapy. 18(11). 1115–1125. 27 indexed citations
5.
Bridgeman, Mary Barna & Daniel Abazia. (2017). Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.. PubMed. 42(3). 180–188. 299 indexed citations breakdown →
6.
Bridgeman, Mary Barna, et al.. (2013). Implementation of a pharmacist-driven pain management consultation service for hospitalised adults with a history of substance abuse. International Journal of Clinical Practice. 67(12). 1342–1349. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026